XCUR
EXICURE, INC.Company Information
- Company Name
- EXICURE, INC.
- CIK
- CIK0001698530
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- XCUR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- XCUR
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-12-26
- Last sale
- 2026-01-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 2,167,718
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 136,690
- Shares outstanding
- 6,373,903
- Ownership
- 2.14%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | 4 | 8 | 10 | - | 0 | 1 | 0 | 1 | 1 | ||||||
| Other Receivables Gross Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 2 | 4 | 5 | 5 | 9 | 11 | 14 | 3 | 2 | 1 | 2 | 3 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | 0 | - | 0 | 0 | 0 | 0 | 6 | 6 | 6 | 7 | 7 | ||||||
| Goodwill | 4 | 4 | 4 | 3 | 3 | 3 | 0 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 0 | - | - | - | - | - | ||||||
| Assets | 11 | 13 | 14 | 15 | 19 | 21 | 15 | 11 | 11 | 11 | 12 | 13 | ||||||
Liabilities Current | ||||||||||||||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | 1 | - | - | - | ||||||
| Accounts Payable Current | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 4 | 4 | 4 | 3 | 5 | 4 | 3 | 4 | 3 | 3 | 3 | 2 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 6 | 6 | 6 | 6 | 5 | 5 | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 5 | 5 | 6 | 6 | 6 | 6 | ||||||
| Liabilities | 10 | 11 | 10 | 8 | 10 | 9 | 8 | 9 | 9 | 9 | 9 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 208 | 208 | 208 | 208 | 208 | 208 | 206 | 194 | 193 | 193 | 193 | 193 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | 0 | 0 | - | 0 | - | - | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -207 | -206 | -204 | -201 | -199 | -196 | -199 | -192 | -191 | -190 | -190 | -188 | ||||||
| Stockholders Equity | 1 | 2 | 4 | 7 | 9 | 11 | 7 | 2 | 2 | 2 | 3 | 4 | ||||||
| Liabilities And Stockholders Equity | 11 | 13 | 14 | 15 | 19 | 21 | 15 | 11 | 11 | 11 | 12 | 13 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 2 | 2 | 2 | 2 | 2 | ||||||
| Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 2 | 2 | 2 | 2 | 2 | ||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEXICURE, INC. (XCUR) — SEC Financial Statements & Analysis
EXICURE, INC. (XCUR) is a pharmaceutical preparations company, incorporated in DE. EXICURE, INC. trades on Nasdaq as: XCUR. EXICURE, INC. (XCUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, EXICURE, INC. carries a market cap of $13.26M, a P/E ratio of -1.60x, a P/B ratio of 13.57x, a P/S ratio of 55.86x, an enterprise value of $11.54M, and an EV/EBITDA multiple of -1.62x. On profitability, it posts an operating margin of -2446.40%, a net margin of -1940.20%, a Return on Equity (ROE) of -168.37%, a Return on Assets (ROA) of -54.98%, and a Return on Invested Capital (ROIC) of -513.34%. Per share, it reports EPS of $-1.30, diluted EPS of $-1.30, free cash flow per share of $-1.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 5.09% year-over-year, and EPS growth of 4.16% year-over-year. On the balance sheet, it maintains a current ratio of 0.56x, a quick ratio of 0.41x, working capital of $-1.85M, a debt-to-equity ratio of 10.67x, a debt ratio of 0.91, an interest coverage ratio of -7341.00x, free cash flow of $-7.02M (TTM), and net debt of $-1.72M. Figures sourced from SEC EDGAR.
- Market Cap
- $13.26M
- P/E TTM
- -1.60x
- EPS TTM
- $-1.30
- P/B TTM
- 13.57x
- ROE TTM
- -168.37%
- ROA TTM
- -54.98%
- Debt To Equity
- 10.67x
- Free Cash Flow TTM
- $-7.02M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is EXICURE, INC. in?
EXICURE, INC. (XCUR) operates in the Pharmaceutical Preparations industry.
What exchange does XCUR trade on?
EXICURE, INC. (XCUR) trades on the Nasdaq.
Where is EXICURE, INC. incorporated?
EXICURE, INC. is incorporated in DE.
When was EXICURE, INC. (XCUR)'s most recent SEC filing?
EXICURE, INC. (XCUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is XCUR's market cap?
EXICURE, INC. (XCUR) has a market capitalization of $13.26M as of 2026-06-30.
What is XCUR's EPS (earnings per share)?
EXICURE, INC. (XCUR)'s trailing twelve month EPS is $-1.30 as of 2026-06-30.
What is XCUR's ROE (return on equity)?
EXICURE, INC. (XCUR)'s trailing twelve month Return on Equity (ROE) is -168.37% as of 2026-06-30.
What is XCUR's ROA (return on assets)?
EXICURE, INC. (XCUR)'s trailing twelve month Return on Assets (ROA) is -54.98% as of 2026-06-30.
What is XCUR's ROIC (return on invested capital)?
EXICURE, INC. (XCUR)'s trailing twelve month Return on Invested Capital (ROIC) is -513.34% as of 2025-09-30.
What is XCUR's EV/EBITDA?
EXICURE, INC. (XCUR)'s trailing twelve month EV/EBITDA is -1.62x as of 2026-06-30.